Berlin, Germany

Carlo Stresemann

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Bayer Pharma Aktiengesellschaft, Bayer Aktiengesellschaft. Active years: 2018-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carlo Stresemann. Retrieved from https://idiyas.com/inventor/carlo-stresemann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 12.3

ph-index = 1


Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Carlo Stresemann: Innovator in Pharmaceutical Chemistry

Introduction

Carlo Stresemann is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating various diseases, including cancer. With a total of two patents to his name, Stresemann's work reflects a commitment to advancing medical science.

Latest Patents

Stresemann's latest patents include innovative compounds such as 4-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-carboxamides. This invention covers a range of compounds that are useful in the treatment or prophylaxis of diseases, particularly cancer. The patent details methods of preparing these compounds, as well as their pharmaceutical compositions and combinations for effective treatment. Another significant patent involves aryl-cyanoguanidine compounds, which serve as inhibitors for protein-lysine N-methyltransferase SMYD2. These compounds are designed for therapeutic use in hyper-proliferative disorders, including various forms of cancer and other serious health conditions.

Career Highlights

Throughout his career, Carlo Stresemann has worked with prominent companies such as Bayer Pharma Aktiengesellschaft and Bayer Aktiengesellschaft. His experience in these organizations has allowed him to collaborate on groundbreaking research and development projects that have the potential to impact the pharmaceutical industry significantly.

Collaborations

Stresemann has collaborated with notable colleagues, including Jörg Weiske and Clara Christ. These partnerships have fostered an environment of innovation and creativity, leading to the development of new therapeutic solutions.

Conclusion

Carlo Stresemann's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments, particularly in the fight against cancer and other serious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…